Drug-Free Approach to Regulate Undruggable Proto-Oncogene MYC Using Biomimetic Porous Nanoparticles for Cancer Immunotherapy
ACS Applied Materials & Interfaces · 2025-08-20 · 17 (33) · 46521-46534
DOI: 10.1021/acsami.5c05042 ↗At a glance
Journal article in ACS Applied Materials & Interfaces, published online on 2025-08-11. Written by Emilia Happonen and 21 co-authors. Institution: Department of Technical Physics, University of Eastern Finland, 70210 Kuopio, Finland. Major MEDLINE topics: Nanoparticles, Proto-Oncogene Proteins c-myc, Immunotherapy, Biomimetic Materials. Cited 5 times so far (Crossref); 56 references. Funded by: Research Council of Finland, Sy?p?s??ti?, National Natural Science Foundation of China.
Abstract (original language)
A proto-oncogene MYC plays a crucial role in controlling immune response, but as of today, it is undruggable. Some MYC inhibitors are under testing; nevertheless, they have low efficacy and severe toxicity. Up to now, the use of a drug-free approach to regulate MYC has been rarely investigated. The present study aims to identify the potential of drug-free photothermal therapy (PTT) in regulating MYC. Herein, biomimetic black porous silicon (BPSi) nanoparticles (NPs) were prepared via a novel self-templated Na-K alloy reduction method and then coated with a cancer cell membrane and polyethylene glycol. These NPs have efficient photothermal conversion, good biocompatibility, and homotypic tumor targeting. The results indicated that BPSi-based PTT could efficiently regulate MYC by tuning temperatures. However, only PTT at 50 °C could successfully inhibit MYC, while PTT at 46 °C upregulated MYC. Mechanism studies revealed that MYC inhibition was achieved via the downregulation of 'MYC Targets V1', and MAPK and JAK-STAT signaling pathways were involved. Finally, tumor-targeted PTT activated robust cancer immunotherapy by MYC inhibition and efficiently prevented tumor growth without significant toxicity in vivo. The present study highlights the potential of a drug-free approach to regulate MYC for more potent cancer immunotherapy.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Technical Physics, University of Eastern Finland, 70210 Kuopio, Finland.
- School of Chemistry and Molecular Engineering, East China Normal University, Shanghai 200241, China.
- Department of Environmental and Biological Sciences, University of Eastern Finland, 70210 Kuopio, Finland.
- School of Pharmacy, University of Eastern Finland, 70210 Kuopio, Finland.
- A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, 70210 Kuopio, Finland.
- Cancer Cell Circuitry Laboratory, Translational Cancer Medicine, University of Helsinki, 00290 Helsinki, Finland.
ORCID profiles: Emilia Happonen, Mohammed Zakir, Konstantin Tamarov, Henri Hakkarainen, Ahmed Bisher Montaser, Henri Leinonen, Haijun Yu, Zhiai Xu, Vesa-Pekka Lehto, Wujun Xu
Funding
- Research Council of Finland
- Sy?p?s??ti?
- National Natural Science Foundation of China
- Suomen Kulttuurirahasto
Cite
APA
Happonen, E., Dang, Y., Wang, J., Saarela, S., Sivonen, M., Zakir, M., Laari, M. I., Constantinou, Y., Tamarov, K., Hakkarainen, H., Montaser, A. B., Leinonen, H., Küblbeck, J., Örd, T., Taipale, M., Kaikkonen, M., Liu, R., Klefström, J., Yu, H., …, & Xu, W. (2025). Drug-Free Approach to Regulate Undruggable Proto-Oncogene MYC Using Biomimetic Porous Nanoparticles for Cancer Immunotherapy. ACS Applied Materials & Interfaces, 17(33), 46521-46534. https://doi.org/10.1021/acsami.5c05042
Vancouver
Happonen E, Dang Y, Wang J, Saarela S, Sivonen M, Zakir M, et al. Drug-Free Approach to Regulate Undruggable Proto-Oncogene MYC Using Biomimetic Porous Nanoparticles for Cancer Immunotherapy. ACS Applied Materials & Interfaces. 2025;17(33):46521-46534. doi:10.1021/acsami.5c05042
BibTeX
@article{Happonen2025,
author = {Happonen, Emilia and Dang, Yijing and Wang, Jiajia and Saarela, Silja and Sivonen, Minna and Zakir, Mohammed and Laari, Milla-Iida and Constantinou, Yiannis and Tamarov, Konstantin and Hakkarainen, Henri and Montaser, Ahmed Bisher and Leinonen, Henri and Küblbeck, Jenni and Örd, Tiit and Taipale, Mari and Kaikkonen, Minna and Liu, Ruixian and Klefström, Juha and Yu, Haijun and Xu, Zhiai and Lehto, Vesa-Pekka and Xu, Wujun},
title = {Drug-Free Approach to Regulate Undruggable Proto-Oncogene MYC Using Biomimetic Porous Nanoparticles for Cancer Immunotherapy},
journal = {ACS Applied Materials & Interfaces},
year = {2025},
volume = {17},
number = {33},
pages = {46521--46534},
doi = {10.1021/acsami.5c05042}
}
EUVIMED